Dormancy of solitary metastatic cells

被引:131
作者
Townson, Jason L.
Chambers, Ann F.
机构
[1] London Reg Canc Program, London, ON N6A 4L6, Canada
[2] Univ Western Ontario, Dept Med Biophys, London, ON, Canada
基金
加拿大健康研究院;
关键词
metastasis; tumor dormancy; solitary cells; tumor recurrence; solitary cell dormancy;
D O I
10.4161/cc.5.16.2864
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
After arriving in a secondary site metastatic cells may begin proliferating, undergo apoptosis or remain as solitary dormant cells. The process of metastasis, although dangerous, is extremely inefficient with the majority of the cells undergoing apoptosis and thus becoming clinically irrelevant. Of the cells that begin proliferating, the few that make it past the micrometastasis stage may be of immediate clinical relevance. Dormant cells, while not of immediate clinical concern, are believed to be at least in part responsible for cancer recurrence that can occur decades after apparently successful initial treatment. Dormant solitary cells are different from "dormant" micrometastases, in which active proliferation is balanced by apoptosis. The mechanisms of cell cycle regulation and the function of the molecules regulating this process are well understood. However, there is relatively little known about the mechanisms controlling cell cycle regulation and dormancy of solitary metastatic cells. There are several inherent difficulties impeding the study of solitary cells. This review paper will examine the models used in the study of dormant solitary metastatic cells, methods of imaging and studying these cells, the molecular mechanisms believed to be responsible for solitary cell dormancy, and finally the unique treatment challenges posed by these cells.
引用
收藏
页码:1744 / 1750
页数:7
相关论文
共 94 条
[1]   Green fluorescent protein tagging of extracellular signal-regulated kinase and p38 pathways reveals novel dynamics of pathway activation during primary and metastatic growth [J].
Aguirre-Ghiso, JA ;
Ossowski, L ;
Rosenbaum, SK .
CANCER RESEARCH, 2004, 64 (20) :7336-7345
[2]   Urokinase receptor and fibronectin regulate the ERKMAPK to p38MAPK activity ratios that determine carcinoma cell proliferation or dormancy in vivo [J].
Aguirre-Ghiso, JA ;
Liu, D ;
Mignatti, A ;
Kovalski, K ;
Ossowski, L .
MOLECULAR BIOLOGY OF THE CELL, 2001, 12 (04) :863-879
[3]  
Aguirre-Ghiso JA, 2003, CANCER RES, V63, P1684
[4]   Prognostic significance of p27 and cyclin D1 co-expression in laryngeal squamous cell carcinoma: Possible target for novel therapeutic strategies [J].
Arisi, E ;
Pruneri, G ;
Carboni, N ;
Sambataro, G ;
Pignataro, L .
JOURNAL OF CHEMOTHERAPY, 2004, 16 :3-6
[5]   Cellular abnormalities of blood vessels as targets in cancer [J].
Baluk, P ;
Hashizume, H ;
McDonald, DM .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2005, 15 (01) :102-111
[6]   The organizing principle: microenvironmental influences in the normal and malignant breast [J].
Bissell, MJ ;
Radisky, DC ;
Rizki, A ;
Weaver, VM ;
Petersen, OW .
DIFFERENTIATION, 2002, 70 (9-10) :537-546
[7]  
Bouvet M, 2002, CANCER RES, V62, P1534
[8]  
Cameron MD, 2000, CANCER RES, V60, P2541
[9]   Expression of angiostatin cDNA in a murine fibrosarcoma suppresses primary tumor growth and produces long-term dormancy of metastases [J].
Cao, YH ;
O'Reilly, MS ;
Marshall, B ;
Flynn, E ;
Ji, RW ;
Folkman, J .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (05) :1055-1063
[10]  
Carlson B, 1999, CANCER RES, V59, P4634